Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philippe Mineur

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
British Journal of Haematology|April 3, 2003
Antibody-targeted chemotherapy of relapsed AMLPhilippe Mineur, Chantal Lejeune, Vincent Hennaux, et al.
Breathe (Sheffield, England)|December 11, 2020
An unusual progressive stridorMatveï Apraxine, Philippe Mineur, Jean Huet, et al.
Acta Clinica Belgica|August 28, 2019
Diabetes insipidus and acute myeloid leukemia harboring monosomy 7: report of two cases and literature reviewHuu Hanh Lê, Jean-Philippe Lengelé, Marie Henin, et al.
Epigenetics|October 31, 2012
HDAC isoenzyme expression is deregulated in chronic lymphocytic leukemia B-cells and has a complex prognostic significanceMichaël Van Damme, Emerence Crompot, Nathalie Meuleman, et al.
Clinical Epigenetics|December 17, 2016
Characterization of TET and IDH gene expression in chronic lymphocytic leukemia: comparison with normal B cells and prognostic significanceMichaël Van Damme, Emerence Crompot, Nathalie Meuleman, et al.
Plos One|September 24, 2010
A molecular score by quantitative PCR as a new prognostic tool at diagnosis for chronic lymphocytic leukemia patientsBasile Stamatopoulos, Nathalie Meuleman, Cécile De Bruyn, et al.
Acta Clinica Belgica|December 23, 2020
Recommendations on the management of multiple myeloma in 2020Marie-Christiane Vekemans, Chantal Doyen, Jo Caers, et al.
Molecular Medicine (Cambridge, Mass.)|January 14, 2015
Opposite Prognostic Significance of Cellular and Serum Circulating MicroRNA-150 in Patients with Chronic Lymphocytic LeukemiaBasile Stamatopoulos, Michaël Van Damme, Emerence Crompot, et al.
Epigenetics|December 2, 2014
Global histone deacetylase enzymatic activity is an independent prognostic marker associated with a shorter overall survival in chronic lymphocytic leukemia patientsMichaël Van Damme, Emerence Crompot, Nathalie Meuleman, et al.
Annals of Hematology|July 22, 2008
Farnesyl transferase inhibitor (lonafarnib) in patients with myelodysplastic syndrome or secondary acute myeloid leukaemia: a phase II studyChristophe Ravoet, Philippe Mineur, Valérie Robin, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
British Journal of Haematology|April 3, 2003
Antibody-targeted chemotherapy of relapsed AMLPhilippe Mineur, Chantal Lejeune, Vincent Hennaux, et al.
Breathe (Sheffield, England)|December 11, 2020
An unusual progressive stridorMatveï Apraxine, Philippe Mineur, Jean Huet, et al.
Acta Clinica Belgica|August 28, 2019
Diabetes insipidus and acute myeloid leukemia harboring monosomy 7: report of two cases and literature reviewHuu Hanh Lê, Jean-Philippe Lengelé, Marie Henin, et al.
Epigenetics|October 31, 2012
HDAC isoenzyme expression is deregulated in chronic lymphocytic leukemia B-cells and has a complex prognostic significanceMichaël Van Damme, Emerence Crompot, Nathalie Meuleman, et al.
Clinical Epigenetics|December 17, 2016
Characterization of TET and IDH gene expression in chronic lymphocytic leukemia: comparison with normal B cells and prognostic significanceMichaël Van Damme, Emerence Crompot, Nathalie Meuleman, et al.
Plos One|September 24, 2010
A molecular score by quantitative PCR as a new prognostic tool at diagnosis for chronic lymphocytic leukemia patientsBasile Stamatopoulos, Nathalie Meuleman, Cécile De Bruyn, et al.
Acta Clinica Belgica|December 23, 2020
Recommendations on the management of multiple myeloma in 2020Marie-Christiane Vekemans, Chantal Doyen, Jo Caers, et al.
Molecular Medicine (Cambridge, Mass.)|January 14, 2015
Opposite Prognostic Significance of Cellular and Serum Circulating MicroRNA-150 in Patients with Chronic Lymphocytic LeukemiaBasile Stamatopoulos, Michaël Van Damme, Emerence Crompot, et al.
Epigenetics|December 2, 2014
Global histone deacetylase enzymatic activity is an independent prognostic marker associated with a shorter overall survival in chronic lymphocytic leukemia patientsMichaël Van Damme, Emerence Crompot, Nathalie Meuleman, et al.
Annals of Hematology|July 22, 2008
Farnesyl transferase inhibitor (lonafarnib) in patients with myelodysplastic syndrome or secondary acute myeloid leukaemia: a phase II studyChristophe Ravoet, Philippe Mineur, Valérie Robin, et al.
Pageof 3